Article
Insights Into China Biotech's New Approach: Spin-Off-NewCo Model
China's pharmaceutical industry is witnessing a notable surge in "pipeline spin-off projects", a model commonly referred to as the "Spin-off-NewCo" or "SON"...

Han Kun Law Offices






